Search

everythinglearnresearchcommunity

for

Search:↓

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

Purpura fulminans can signal underlying autoimmune disorders, not just infections.

Antiphospholipid syndrome can severely damage adrenal glands, requiring early diagnosis and treatment.

Anti-CD19 therapy may help treat SLE and NMOSD.

Atypical symptoms in lupus can indicate different kidney issues.

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.

Correct diagnosis is crucial for treating overlapping conditions like NMOSD and SLE effectively.

Catatonia can be a rare sign of lupus, needing careful diagnosis and treatment.

PRP shows promise in musculoskeletal rehabilitation but needs standardized reporting for better outcomes.

Lupus enteritis is a rare but serious gut inflammation in lupus patients, often hard to diagnose without prior lupus symptoms.

Early identification of lupus through skin signs and blood tests is crucial in India.

A 16-year-old boy with lupus had a rare brain artery issue but fully recovered with treatment.

PRP may help with hair loss and improve hair quality with few side effects, but more research is needed.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Platelet-Rich Plasma (PRP) shows promise for hair growth and skin improvement in aesthetic surgery.

Hair restoration surgery can have complications; success depends on patient education, careful planning, and proper execution.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

COVID-19 can harm many body parts, not just the lungs.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

The model and estimator can predict drug exposure in kidney transplant patients well.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Personalized treatment and teamwork among doctors can reduce chemotherapy side effects and improve patient outcomes.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.